Clariant Says in Advanced Talks to Ramp Up Biofuels Business

Clariant AG is in advanced talks with potential partners that can build a bioethanol factory to generate additional revenue from enzyme technology acquired through the $2.5 billion purchase of Sued-Chemie.

The Swiss company wants a partner to build a second-generation biofuel plant capable of generating as much as 150,000 tons based on its Sunliquid enzyme technology, Markus Rarbach, head of Clariant’s Biofuels & Derivatives business, said in a telephone interview today.